EFSD/Sanofi European Diabetes Research Programme in Macrovascular Complications of Diabetes


Georgios Georgiopoulos: King's College London - UK
Early diagnosis of diabetic cardiomyopathy by comprehensive MR imaging

Ronan Roussel: AP-HP, Bichat Hospital - Paris, France
Targeting glutamine metabolism to prevent diabetic cardiovascular complications


Stefano Menini: Sapienza University of Rome - Italy
Might Warburg rescue the unifying hypothesis of diabetic complications?

Marleen van Greevenbroek: Maastricht University - Netherlands
An alternative path towards macrovascular complications in type 2 diabetes

Kristiaan Wouters: Maastricht University - Netherlands
A unique blood immune cell signature for macrovascular complications of diabetes


Hans Niessen: Free University Amsterdam Medical Centre - Netherlands
Targeted mesenchymal stem cell therapy to limit macrovascular inflammation in diabetes

Cesare Patrone: Karolinska Institutet - Stockholm, Sweden
Stroke recovery in diabetes: mechanisms and therapies based on glucagon-like peptide 1 receptor activation

John Pernow: Karolinska Institutet - Stockholm, Sweden
The novel role of red blood cells in development of macrovascular complications in type 2 diabetes

Niina Sandholm: Folkhälsan Research Center - Helsinki, Finland
Discovery of genetic factors affecting the pathogenesis of cardiovascular disease in patients with type 1 diabetes


Martijn Brouwers: Maastricht University Medical Centre - Netherlands
Hepatic de novo lipogenesis: the missing link between type 2 diabetes and cardiovascular disease

Claudia Menzaghi: IRCCS "Casa Sollievo della Sofferenza" - San Giovanni Rotondo, Italy
Role of a multi-cytokine resistin pathway on cardiovascular disease and mortality in patients with type 2 diabetes